01 1Concord Biotech
01 1VOCLOSPORIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-31
Pay. Date : 2024-10-15
DMF Number : 40644
Submission : 2024-10-16
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VOCLOSPORIN, with a corresponding US DMF Number 40644.
Remarkably, this DMF maintains an Active status since its submission on October 16, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 31, 2024, and payment made on October 15, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
